Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 1
2020 1
2022 2
2023 3
2024 3
2025 7
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.
Oszer A, Galimard JE, Wardell JR, Devidas M, Dalissier A, Perez-Martinez A, Bolous NS, Janczar S, Styczyński J, Yakimkova T, Rodriguez-Galindo C, Młynarski W, Agulnik A, Duffy C, Kałwak K, Schmiegelow K; St Jude Global, the European Group for Blood and Marrow Transplantation (EBMT) PDWP and the International BFM Study Group (I-BFM). Oszer A, et al. Among authors: duffy c. JCO Glob Oncol. 2026 Jun;12(6):e2600050. doi: 10.1200/GO-26-00050. Epub 2026 Jun 4. JCO Glob Oncol. 2026. PMID: 42241651
Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review.
Duffy C, Allen S, Alexander TB, Andrew EC, Bhakta M, Bolous NS, Bonilla M, Force LM, Habashy C, Hassan J, McMillan C, McNeil MJ, Salek M, Ureda T, Wang'ondu R, Wing-Yan Yuen B, Devidas M, Brandt HM, Hermiston ML, Bhakta N. Duffy C, et al. JCO Glob Oncol. 2025 Dec;11:e2500286. doi: 10.1200/GO-25-00286. Epub 2025 Dec 15. JCO Glob Oncol. 2025. PMID: 41397197
Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma.
Krasnow N, Maurer K, Song C, Rhoades J, Xiong K, Crnjac A, Blewett T, Gao L, Jacene H, Merryman R, Gohil SH, Duffy C, Guerrero LI, Dela Cruz J, McDonough M, Wolff JO, Redd R, Mattie M, Miles B, Makrigiorgos GM, Neuberg DS, Rodig SJ, Armand P, Jacobson C, Adalsteinsson VA, Wu CJ. Krasnow N, et al. Among authors: duffy c. Blood Adv. 2025 Nov 11;9(21):5539-5545. doi: 10.1182/bloodadvances.2024015788. Blood Adv. 2025. PMID: 40706054 Free PMC article.
Landscape assessment to characterize baseline access and multilevel barriers to IMProve Access to CAR-T CD19 therapy (IMPACT study) across Europe.
Oszer A, Galimard JE, Wardell JR, Devidas M, Dalissier A, Perez-Martinez A, Bolous NS, Janczar S, Styczyński J, Yakimkova T, Rodriguez-Galindo C, Młynarski W, Agulnik A, Duffy C, Kałwak K, Schmiegelow K. Oszer A, et al. Among authors: duffy c. medRxiv [Preprint]. 2025 Nov 6:2025.11.04.25339516. doi: 10.1101/2025.11.04.25339516. medRxiv. 2025. Update in: JCO Glob Oncol. 2026 Jun;12(6):e2600050. doi: 10.1200/GO-26-00050. PMID: 41282698 Free PMC article. Updated. Preprint.
Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.
Vanni KMM, McCarter KR, Wang X, Duffy C, Cruz JPD, Wobma H, Nikiforow S, Massarotti EM, Costenbader KH, Little JS, Gravallese EM, McDermott GC, Jacobson CA, Sparks JA. Vanni KMM, et al. Among authors: duffy c. Lancet Rheumatol. 2025 Apr;7(4):e226-e229. doi: 10.1016/S2665-9913(24)00402-8. Epub 2025 Jan 28. Lancet Rheumatol. 2025. PMID: 39889722 No abstract available.
A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.
Looka A, Qualls DA, Matthews D, Redd RA, Sakellis C, Duffy C, Dela Cruz J, Saucier A, Armand P, Crombie JL, Fisher DC, Jacobsen ED, Kim AI, LaCasce AS, Merryman RW, Parry EM, Jacobson CA. Looka A, et al. Among authors: duffy c. Blood Adv. 2025 Feb 11;9(3):455-462. doi: 10.1182/bloodadvances.2024012992. Blood Adv. 2025. PMID: 39546746 Free PMC article.
Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.
Itzhaki Ben Zadok O, Simitsis P, Jacobson C, Nadeem O, Frigault MJ, Raje N, Duffy C, Costello P, Dela Cruz J, Looka A, Nohria A. Itzhaki Ben Zadok O, et al. Among authors: duffy c. Circulation. 2024 Nov 26;150(22):1815-1817. doi: 10.1161/CIRCULATIONAHA.124.070432. Epub 2024 Nov 25. Circulation. 2024. PMID: 39585929 No abstract available.
19 results